Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Hormonal therapies effectively treat acne and improve quality of life.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Minoxidil and finasteride are key treatments for hair loss.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Sex hormones, especially androgens, play a key role in causing acne.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Placenta products might help with hair loss, but more research is needed.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.